Targeting CD38 Across Autoimmune and Plasma Cell-Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape. [PDF]
Roccatello D +3 more
europepmc +1 more source
Pragmatic Clinical Trial of Fostamatinib as Second-Line Therapy in Adult Patients With Immune Thrombocytopenia and Insufficient Response to Prior Therapy: The Fostamatinib FORTE Trial. [PDF]
Afzal A +8 more
europepmc +1 more source
Avatrombopag in heavily pretreated chronic immune thrombocytopenia: a single center experience from Oman. [PDF]
Al-Sharji N +3 more
europepmc +1 more source
Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up. [PDF]
Yuan Y +8 more
europepmc +1 more source
Evaluation of <i>CD16</i>, <i>CD32</i>, <i>CD40</i>, and <i>CD152</i> polymorphisms in immune thrombocytopenia patients: a systematic review, meta-analysis, and trial sequential analysis. [PDF]
Pan Y, Chen F, Wang Y.
europepmc +1 more source
Neutrophil-derived S100A8/A9 impairs megakaryocyte maturation in immune thrombocytopenia. [PDF]
Qi J +12 more
europepmc +1 more source
Freely accessible large language models for parent education in pediatric immune thrombocytopenia: an expert-rated cross-sectional study of safety, readability, and guideline concordance. [PDF]
Dinç O, Akay E, Ates B.
europepmc +1 more source
Maternal Bleeding Outcomes in Pregnant Women With Immune Thrombocytopenia (ITP): A National Database Study. [PDF]
Araji M +7 more
europepmc +1 more source
Periampullary GIST in a neurofibromatosis type 1 patient with idiopathic thrombocytopenic purpura - a rare case report at a tertiary care center in Bangladesh. [PDF]
Probal MSI +5 more
europepmc +1 more source

